SCHEMBL7694680

SCHEMBL7694680

COc1ccc(C=Cc2ccccc2C(=O)N[C@@H](Cc2ccccc2)C(=O)CNS(C)(=O)=O)cc1OC

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CAPN1 P07384 9/20 0.72
CTSB P07858 5/20 0.53
CTSL P07711 3/20 0.53
CTSS P25774 3/20 0.49
CTSK P43235 2/20 0.49
KDM4E B2RXH2 2/20 0.45
LMNA P02545 1/20 0.45
CNR2 P34972 1/20 0.44
ALDH1A1 P00352 3/20 0.43
TAS1R3 Q7RTX0 1/20 0.43
TAS1R1 Q7RTX1 1/20 0.43
FPR2 P25090 1/20 0.41
TSHR P16473 1/20 0.41
HPGD P15428 1/20 0.41
HTT P42858 1/20 0.41
CYP1A1 P04798 1/20 0.41
CYP1A2 P05177 1/20 0.41
CYP19A1 P11511 1/20 0.41
CYP1B1 Q16678 1/20 0.41
KMT2A Q03164 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7695839 0.92 CAPN1 (0.70) CAPN1CTSBCTSLCTSSCTSK
SCHEMBL7691777 0.87 CAPN1 (0.58) CAPN1CTSBCTSLCTSSCTSK
SCHEMBL7690013 0.87 CAPN1 (0.68) CAPN1CTSBCTSLCTSSCTSK
SCHEMBL7688971 0.83 CAPN1 (0.51) CAPN1CTSBCTSLCTSSCTSK
SCHEMBL7694140 0.82 CAPN1 (0.60) CAPN1CTSBCTSLCTSSCTSK
SCHEMBL7690746 0.80 CAPN1 (0.56) CAPN1CTSBCTSLCTSSCTSK
SCHEMBL7787056 0.80 CAPN1 (1.00) CAPN1CTSBCTSLCTSSCTSK
SCHEMBL7791353 0.80 CAPN1 (0.75) CAPN1CTSBCTSLCTSSCTSK
SCHEMBL7791357 0.80 CAPN1 (0.75) CAPN1CTSBCTSLCTSSCTSK
SCHEMBL7787053 0.80 CAPN1 (1.00) CAPN1CTSBCTSLCTSSCTSK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6436925-B1 BETTER ABLE TO CROSS MEMBRANES; INHIBITORS OF CYSTEINE PROTEASES LIKE CALPAIN I AND II AND CATHEPSIN B AND L, CAN THUS BE USED TO CONTROL DISEASES ASSOCIATED WITH AN ELEVATED ACTIVITY OF CALPAIN ENZYMES OR CATHEPSIN ENZYMES ABBOTT LABORATORIES 2002-08-20 US disclosed